麗新發展(00488.HK)擬8000萬港元出售香港物業
格隆匯3月15日丨麗新發展(00488.HK)發佈公吿,於2024年3月15日,賣方(麗新發展全資附屬公司)與買方訂立臨時買賣協議,內容有關出售該物業,代價為8000萬港元。
該物業為非住宅物業,包括香港新界葵涌大連排道192-200號偉倫中心二期(亦稱偉倫中心2期)(i)二十樓及(ii)二樓P17、P18及P59號停車位。
該物業由麗新發展集團收購,目前由麗新發展集團成員公司自用。出售事項為麗新發展集團對其非核心資產出售計劃的承諾,使麗新發展集團可就完善資本架構及╱或麗新發展集團的一般企業用途重新分配更多財務資源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.